Clinical Genomics Malpractice Law In Russia.
1. Introduction
Clinical Genomics Malpractice Law in Russia concerns the legal responsibility of doctors, genetic laboratories, hospitals, medical organisations and biotechnology institutions when they make errors in genetic testing, genomic diagnosis, interpretation of genetic variants, genetic counselling or genomic-based treatment.
Clinical genomics uses DNA sequencing, whole-genome sequencing (WGS), whole-exome sequencing (WES), pharmacogenomics and molecular diagnostic techniques to identify inherited diseases, cancer risks, hereditary disorders and potential responses to medicines.
Malpractice can occur when a healthcare professional:
Misinterprets a pathogenic genetic variant.
Provides an incorrect hereditary disease diagnosis.
Fails to identify a clinically significant mutation.
Conducts genetic testing without valid informed consent.
Reports another patient's genetic results.
Fails to communicate important incidental findings.
Recommends inappropriate treatment based on inaccurate genomic information.
Fails to protect confidential genetic information.
Uses an unreliable or inadequately validated genomic testing method.
Important legal distinction: Russia does not have one comprehensive statute specifically titled Clinical Genomics Malpractice Law. Liability is determined through general medical malpractice, healthcare, civil liability, criminal law, personal-data protection and medical licensing provisions.
2. Legal Framework Governing Clinical Genomics Malpractice
The principal legislation includes the following:
| Legal instrument | Relevance |
|---|---|
| Constitution of the Russian Federation | Protection of dignity, privacy and health |
| Federal Law No. 323-FZ of 21 November 2011 | Fundamental patient rights and medical liability |
| Civil Code of the Russian Federation | Compensation for injury and moral damage |
| Federal Law No. 152-FZ of 27 July 2006 | Personal data and genetic information protection |
| Federal Law No. 61-FZ of 12 April 2010 | Regulation of medicines |
| Federal Law No. 99-FZ of 4 May 2011 | Licensing of relevant activities |
| Criminal Code of the Russian Federation | Criminal responsibility for qualifying medical negligence and other offences |
The most important legislation is Federal Law No. 323-FZ, On the Fundamentals of Health Protection of Citizens in the Russian Federation.
Article 19 establishes patient rights, including the right to medical care, information about health and the protection of medical confidentiality.
Article 20 governs informed voluntary consent to medical intervention and refusal of medical intervention.
Article 22 establishes the patient's right to receive information about their health condition, diagnosis and treatment.
Article 13 protects medical confidentiality.
These provisions are particularly important because genomic testing can reveal information about both the patient and biological relatives.
3. Civil Liability for Clinical Genomics Malpractice
Civil liability is principally governed by the Civil Code of the Russian Federation.
A. Article 1064 – General liability for causing harm
Article 1064 establishes the general obligation to compensate harm caused to another person.
For example, if a genetic laboratory incorrectly identifies a pathogenic mutation and the error results in inappropriate treatment, the patient may seek compensation.
The claimant generally needs to establish:
Actual harm or injury.
Unlawful conduct or failure to meet applicable professional requirements.
A causal connection between the misconduct and the harm.
The relevant basis for attributing liability.
The defendant may seek to establish the absence of fault.
B. Article 1068 – Liability for employees
A medical organisation may be liable for harm caused by its employees while performing their professional duties.
This provision can apply where a hospital's geneticist, laboratory technician or medical specialist makes a negligent professional error in the course of employment.
C. Article 1099 – Compensation for moral damage
Patients may seek compensation for non-material harm where the statutory requirements are satisfied.
Examples include:
Emotional suffering caused by an incorrect hereditary diagnosis.
Psychological injury resulting from disclosure of confidential genomic information.
Distress caused by a negligent prenatal genetic diagnosis.
Serious interference with personal and family privacy.
D. Article 1100 – Compensation irrespective of fault in specified circumstances
This provision identifies particular circumstances in which moral damage may be compensated independently of fault. It should not be interpreted as creating automatic no-fault liability for every genomic testing error.
4. Major Types of Clinical Genomics Malpractice
4.1. Misdiagnosis of Genetic Disorders
Genetic misdiagnosis occurs when a medical professional incorrectly interprets genomic findings or fails to identify a clinically relevant genetic abnormality.
Examples include:
Failure to identify a disease-causing BRCA1 or BRCA2 variant.
Incorrect interpretation of a pathogenic CFTR variant.
Misdiagnosis of hereditary neurological disorders.
Incorrect classification of a genetic variant of uncertain significance (VUS).
Legal consequences: Depending on the evidence, the medical organisation may face civil liability for diagnostic negligence, inadequate medical services and resulting injury.
A genetic variant of uncertain significance should not automatically be treated as pathogenic. Clinical interpretation must take account of the evidence, the patient's phenotype and relevant professional standards.
4.2. Prenatal Genetic Testing Negligence
Prenatal genetic testing raises particularly difficult questions concerning professional responsibility.
Potential malpractice includes:
Failure to recommend an indicated diagnostic investigation.
Incorrect interpretation of prenatal screening results.
Failure to explain the limitations of non-invasive prenatal testing (NIPT).
Incorrect reporting of chromosomal abnormalities.
Failure to refer a patient for appropriate genetic counselling.
A distinction must be made between screening and diagnostic testing. A positive screening result does not necessarily establish that a fetus has a particular genetic disorder.
Russian courts may consider whether the medical organisation provided appropriate information, followed applicable clinical recommendations and obtained valid informed consent.
4.3. Laboratory Sequencing Errors
Genomic laboratories can incur liability for technical and administrative failures, including:
Sample contamination.
DNA sample misidentification.
Sequencing errors.
Incorrect reference genome selection.
Failure to conduct appropriate quality control.
Incorrect bioinformatics analysis.
Inaccurate variant classification.
Reporting another patient's genetic results.
A laboratory's responsibility depends on its contractual obligations, applicable licensing and technical requirements, the nature of the error and its causal connection with the patient's injury.
4.4. Failure to Provide Genetic Counselling
Genetic counselling is important because genomic results can affect patients and their biological relatives.
A professional may be negligent where they fail to explain:
The meaning of a genetic variant.
The probability of inheriting a disorder.
The limitations of genetic testing.
The implications of incidental findings.
The availability of further diagnostic investigations.
The potential implications for family members.
The duty to communicate must be assessed in light of the patient's consent, the applicable professional standards and the confidentiality obligations imposed by Russian law.
4.5. Pharmacogenomic Treatment Errors
Pharmacogenomics examines how genetic variations influence responses to medicines.
Malpractice may arise when a doctor:
Ignores clinically relevant pharmacogenomic results.
Prescribes an inappropriate medication despite relevant genetic information.
Misinterprets a genetic drug-metabolism report.
Fails to consider relevant contraindications.
Uses an inadequately validated genomic test to determine treatment.
The existence of a genetic test does not automatically create a legal obligation to order it in every case. The question is whether testing or consideration of its results was clinically indicated under the applicable standards.
5. Medical Confidentiality and Genetic Data Protection
Genomic information is especially sensitive because it may reveal hereditary disease risks, biological relationships and information about relatives.
Two major laws are relevant.
Federal Law No. 152-FZ – Personal Data
Article 10 regulates special categories of personal data, including information concerning health.
Article 5 establishes principles such as purpose limitation, proportionality and restrictions on excessive processing.
Article 6 regulates the legal grounds for processing personal data.
Federal Law No. 323-FZ – Article 13
Article 13 protects medical confidentiality. Information obtained during medical examination and treatment generally cannot be disclosed without an appropriate legal basis.
For example, a genetic laboratory that improperly discloses a patient's hereditary cancer-risk report could face legal consequences under applicable data-protection and medical-confidentiality provisions.
A particularly difficult issue arises when a patient's genetic result reveals a serious hereditary risk affecting biological relatives. The patient's confidentiality rights must be balanced against any applicable statutory basis for disclosure; a relative does not automatically acquire a right to the patient's complete genetic report.
6. Criminal Liability for Clinical Genomics Malpractice
In serious cases, criminal responsibility may arise under the Russian Criminal Code.
| Provision | Potential relevance |
|---|---|
| Article 109 | Causing death by negligence |
| Article 118 | Causing serious harm to health through negligence |
| Article 124 | Failure to provide assistance to a patient, where statutory elements are established |
| Article 238 | Providing services that do not meet safety requirements, where its elements apply |
| Article 293 | Negligence by an official |
For instance, if a responsible medical professional's serious negligent conduct causes a patient's death, Article 109 may become relevant.
If a laboratory or healthcare provider supplies services that fail applicable safety requirements and the statutory elements of Article 238 are established, criminal proceedings may also be possible.
Important: A poor clinical outcome, an incorrect genetic prediction or a disputed interpretation does not automatically constitute a criminal offence. The prosecution must establish the elements of the particular offence, including the necessary form of fault and causation.
7. Important Russian Case Laws and Judicial Decisions
There is an important qualification when researching this subject: published Russian decisions specifically addressing whole-genome sequencing errors or genetic variant misclassification are limited. Therefore, the following decisions include directly relevant reproductive-genetics litigation and broader medical-malpractice precedents that can be applied by analogy.
Case 1. Fourth Cassation Court of General Jurisdiction – Genetic Disease and Assisted Reproduction Dispute
Case concerning ООО «Клиника «Первое слово»; cassation proceedings reported in the court's published case record.
Facts:
The claimants challenged the quality of paid assisted-reproduction services following the birth of a child with a genetic disease.
They sought recovery of 206,000 roubles paid under their medical-services contract, together with moral-damage compensation.
The dispute concerned whether the clinic had been obliged to provide genetic counselling and recommend additional genetic investigations.
Legal issues:
Whether genetic counselling formed part of the agreed medical services.
Whether additional mutation testing was clinically indicated.
Whether the clinic had breached its contractual or professional obligations.
Whether the alleged deficiencies were established by expert evidence.
Judicial significance:
The appellate court considered the contract's scope and expert evidence, finding that the contracted services did not include genetic counselling and that the evidence did not establish a failure to provide the agreed services.
The Fourth Cassation Court identified significant procedural problems, including the absence of prosecutorial participation, and the proceedings were subject to further judicial consideration.
Relevance: This dispute illustrates that a genetic disease in a child does not automatically establish malpractice by an IVF clinic. The court must examine the agreed services, clinical indications, professional duties and evidence.
Source:
4kas.sudrf.ru
Case 2. Supreme Court of the Russian Federation – 24 June 2019, No. 74-КГ19-5
Subject: Compensation for moral damage caused by inadequate medical care.
Facts and legal issues:
The Supreme Court considered a claim concerning allegedly poor-quality medical assistance and the lower courts' assessment of the applicable healthcare quality-control rules.
The dispute concerned the proper application of civil liability provisions and the rules governing the assessment of medical-care quality.
Legal principles:
The Supreme Court referred to:
Article 1064 of the Civil Code.
Article 1099 of the Civil Code.
Article 151 of the Civil Code.
The legal framework governing the quality and conditions of medical assistance.
Relevance to genomics:
A patient alleging negligent genetic diagnosis may rely on these principles when seeking compensation for injury or moral damage.
For example, where a hospital fails to investigate a suspected hereditary disease adequately, the court must consider the applicable standards and whether the failure caused legally recognisable harm.
Source:
ГАРАНТ
Case 3. Seventh Cassation Court of General Jurisdiction – 12 September 2024, No. 8Г-14827/2024
Subject: Failure to diagnose cancer and inadequate medical treatment.
Facts:
The case concerned a patient's prolonged failure to receive an accurate diagnosis of lung cancer. The patient's widow sought one million roubles in moral-damage compensation.
Medical experts identified several diagnostic and treatment deficiencies, including delayed investigation, inadequate interpretation of clinical findings and failure to arrange appropriate oncological assessment.
The medical experts could not conclusively establish that the deficiencies directly caused the patient's death.
Judicial significance:
The Seventh Cassation Court examined the lower courts' treatment of medical negligence, causation and moral-damage compensation.
The decision is particularly useful because it explains that courts must examine the overall quality of diagnosis and treatment, including whether medical professionals took the necessary steps to identify the correct disease.
Relevance to clinical genomics:
The same reasoning can be relevant when a genetic laboratory or clinician fails to investigate clinically significant genomic findings or delays a necessary diagnostic referral.
However, this is an oncology malpractice precedent, not a genetic-testing judgment.
Source:
ГАРАНТ
Case 4. Supreme Court Plenum Resolution No. 33 of 15 November 2022
Subject: Judicial practice concerning compensation for moral damage.
This is a significant general judicial authority rather than an individual patient judgment.
Paragraph 48 addresses the responsibility of medical organisations and medical professionals for violations of patient rights and harm resulting from inadequate medical care.
Courts should consider:
Whether appropriate and possible diagnostic measures were taken.
Whether medical investigations complied with applicable procedures and clinical recommendations.
Whether diagnostic deficiencies affected treatment decisions.
Whether the deficiencies contributed to deterioration in the patient's health.
Whether the patient's rights were violated.
Relevance: These principles provide a strong legal foundation for evaluating genomic diagnostic negligence, including incorrect interpretation of genetic results and failure to act on clinically significant findings.
Source:
Верховный Суд Российской Федерации+1
Case 5. Eighth Cassation Court – 15 October 2024, No. 8Г-19249/2024
Subject: Medical organisation's responsibility for inadequate medical assistance.
The decision discusses the application of Paragraph 48 of Supreme Court Plenum Resolution No. 33.
It recognises the importance of examining medical-care deficiencies, their relationship with the patient's condition and the medical organisation's responsibility.
Relevance: In genomic malpractice litigation, this approach supports examination of laboratory quality assurance, professional qualifications, clinical recommendations and the causal relationship between diagnostic errors and patient harm.
Source:
ГАРАНТ
8. Establishing Negligence in Clinical Genomics Cases
Russian courts need more than evidence that a genetic test produced an incorrect result. The claimant must establish the relevant legal elements of liability.
The following framework is useful:
Clinical genomics malpractice assessment
Professional duty
Did the doctor or laboratory have a duty to perform, interpret or communicate the genomic investigation properly?
Breach of duty
Was there a departure from applicable clinical recommendations, professional requirements, technical standards or contractual obligations?
Actual harm
Did the patient suffer physical injury, financial loss or legally recognisable moral damage?
Causation
Did the diagnostic or laboratory error cause or contribute to the injury?
Legal responsibility
Which individual or organisation is legally responsible, and what compensation or other remedy is available?
9. Role of Medical and Genetic Expert Evidence
Expert evidence is particularly important because genomic medicine involves complex scientific questions.
Under Russian procedural law, courts can obtain expert opinions to establish medical and scientific facts.
Relevant evidence may include:
Original sequencing files and laboratory reports.
DNA sample identification records.
Quality-control documentation.
Variant classification reports.
Clinical recommendations applicable at the time.
Patient consent documents.
Genetic counselling records.
Medical histories and treatment records.
Independent specialist opinions.
A court may require experts to address questions such as:
Was the genomic test technically reliable?
Was the genetic variant correctly classified?
Was the interpretation consistent with the available scientific evidence at the relevant time?
Should further testing have been recommended?
Was the patient appropriately informed?
Did the error cause or contribute to the injury?
An expert's conclusion assists the court but does not automatically determine the legal outcome.
10. Liability of Genetic Laboratories and Medical Institutions
Different organisations may have different responsibilities.
| Responsible party | Potential legal responsibility |
|---|---|
| Geneticist | Incorrect interpretation or inadequate counselling |
| Laboratory | Sequencing, sample-handling and reporting errors |
| Hospital | Inadequate diagnostic and treatment systems |
| IVF clinic | Negligent reproductive-genetics services |
| Medical director | Management failures, where legally attributable |
| Data operator | Unlawful processing or disclosure of genetic data |
Under Article 98 of Federal Law No. 323-FZ, medical organisations and medical professionals may be held responsible for violations of healthcare rights and harm caused during medical assistance.
Article 1068 of the Civil Code may also make an employer organisation liable for harm caused by an employee performing employment duties.
11. Patient Rights and Available Legal Remedies
A patient affected by clinical genomics malpractice may pursue several remedies, depending on the circumstances.
A. Civil compensation
The patient may seek:
Compensation for proven financial losses.
Medical and rehabilitation expenses.
Compensation for legally recognised moral damage.
Other recoverable damages under applicable civil law.
B. Administrative complaints
Complaints may be submitted to relevant authorities, including:
Roszdravnadzor – Federal Service for Surveillance in Healthcare.
Roskomnadzor – Federal Service for Supervision of Communications, Information Technology and Mass Media, for relevant personal-data matters.
Relevant regional healthcare authorities.
C. Criminal proceedings
Where the statutory elements of a criminal offence are established, an investigation may be initiated under the relevant provisions of the Criminal Code.
D. Judicial protection
Patients may bring claims before competent Russian courts seeking appropriate compensation and protection of their rights.
12. Hypothetical Case Study
Case: Incorrect BRCA1 Genetic Test Interpretation
A woman undergoes genetic testing because several members of her family have experienced breast cancer.
The laboratory identifies a clinically significant BRCA1 mutation but incorrectly reports the result as benign.
The treating doctor relies on the report and does not recommend further assessment.
Several years later, the patient develops breast cancer.
Potential legal issues:
Whether the laboratory correctly analysed and classified the mutation.
Whether the laboratory complied with applicable quality requirements.
Whether the doctor reasonably relied on the laboratory report.
Whether additional investigations or specialist referral were indicated.
Whether the incorrect report caused a legally relevant delay in diagnosis or treatment.
Whether the patient's resulting injury is attributable to the defendants.
Possible legal provisions:
Civil Code Article 1064 – compensation for harm.
Civil Code Article 1068 – employer liability.
Civil Code Article 151 – moral-damage compensation.
Federal Law No. 323-FZ, Articles 13, 19, 20, 22 and 98.
Federal Law No. 152-FZ – personal-data protection.
The laboratory and healthcare organisation could face civil liability if the relevant breaches, injury and causal connection are established.
Importantly, the fact that the patient developed cancer does not itself prove that the incorrect report caused the cancer or that an earlier intervention would necessarily have prevented it.
13. Challenges in Russian Clinical Genomics Malpractice Law
Several legal and scientific challenges remain important.
1. Scientific uncertainty: Genetic variants may be reclassified as scientific knowledge develops. Negligence must be assessed using the evidence and professional standards applicable when the test was performed.
2. Lack of genomics-specific malpractice legislation: General medical liability provisions must be applied to specialised genomic procedures.
3. Causation difficulties: It may be difficult to establish whether an earlier genetic diagnosis would have prevented a disease or improved its outcome.
4. Laboratory accountability: Responsibility may be divided between the testing laboratory, interpreting geneticist and treating doctor.
5. Genetic privacy: Genomic information can reveal hereditary risks affecting several members of a family.
6. Cross-border testing: Foreign laboratories and overseas genomic databases create additional questions concerning applicable law, contractual responsibility, personal-data transfers and enforcement.
7. Artificial intelligence: AI-based variant interpretation introduces questions concerning validation, human oversight, explainability and responsibility for automated diagnostic errors.
14. Suggestions for Legal and Regulatory Development
Russia could strengthen clinical genomics accountability through:
Specific professional standards for clinical geneticists.
Mandatory accreditation and quality-control requirements for genomic laboratories.
Clear rules for interpreting variants of uncertain significance.
Standardised consent procedures for whole-genome and whole-exome sequencing.
Requirements for documenting AI-assisted genomic decisions.
Independent investigation procedures for serious genomic diagnostic errors.
Clearer requirements for communicating incidental findings.
Stronger protection against unauthorised disclosure of hereditary information.
Improved access to independent genetic and medical expertise in litigation.
More transparent procedures for reporting and correcting inaccurate genetic test results.
15. Conclusion
Clinical Genomics Malpractice Law in Russia is an emerging area at the intersection of medical negligence, biotechnology regulation, civil liability, criminal law and genetic-data protection.
Federal Law No. 323-FZ, the Civil Code and Federal Law No. 152-FZ provide the principal legal framework.
The Russian Supreme Court's Resolution No. 33 of 15 November 2022 is particularly important because it explains how courts should evaluate diagnostic deficiencies, inadequate treatment and moral-damage claims.
The reproductive-genetics dispute before the Fourth Cassation Court and medical-malpractice decisions such as No. 74-КГ19-5 and No. 8Г-14827/2024 provide useful judicial guidance, although they should not be misrepresented as judgments establishing a specific genomic-malpractice doctrine.
Ultimately, liability depends on professional obligations, the quality of the genomic investigation, informed consent, actual harm and legally sufficient causation.
16. Important Legal References
| Authority | Subject |
|---|---|
| Constitution, Article 21 | Human dignity |
| Constitution, Article 23 | Privacy and personal secrets |
| Federal Law 323-FZ, Article 13 | Medical confidentiality |
| Federal Law 323-FZ, Article 19 | Patient rights |
| Federal Law 323-FZ, Article 20 | Informed consent |
| Federal Law 323-FZ, Article 22 | Health information |
| Federal Law 323-FZ, Article 37 | Organisation of medical care |
| Federal Law 323-FZ, Article 64 | Medical-care quality assessment |
| Federal Law 323-FZ, Article 98 | Liability in healthcare |
| Federal Law 152-FZ, Articles 5, 6 and 10 | Personal-data processing |
| Civil Code, Articles 1064 and 1068 | Civil and employer liability |
| Civil Code, Articles 151 and 1099–1101 | Moral-damage compensation |
| Criminal Code, Articles 109, 118 and 124 | Relevant criminal offences |
Primary research sources:
Supreme Court of Russia – Plenum Resolution No. 33 (2022).
Seventh Cassation Court – Case No. 8Г-14827/2024.
Fourth Cassation Court – reproductive-genetics dispute.
Supreme Court – Case No. 74-КГ19-5 (2019).
Federal Law No. 152-FZ – Personal Data.
Academic note: This is a general research explanation, not an exhaustive survey of Russian case law or a substitute for advice on an individual dispute. Statutory amendments and the full text of judgments should be checked before formal legal citation.

comments